Medicare wants to curb lock-in drug pricing, under which some pharmacy benefits managers mark up drugs they sell to health insurers--and ultimately, the government. Report [1]
Links:
[1] http://online.wsj.com/article/SB121668516741472029.html?mod=2_1566_topbox